These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16503388)

  • 1. Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms.
    Guse C; Koennings S; Kreye F; Siepmann F; Goepferich A; Siepmann J
    Int J Pharm; 2006 May; 314(2):137-44. PubMed ID: 16503388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms controlling protein release from lipidic implants: effects of PEG addition.
    Herrmann S; Winter G; Mohl S; Siepmann F; Siepmann J
    J Control Release; 2007 Apr; 118(2):161-8. PubMed ID: 17275943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug release mechanisms of compressed lipid implants.
    Kreye F; Siepmann F; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):27-35. PubMed ID: 21055453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmable implants--from pulsatile to controlled release.
    Guse C; Koennings S; Blunk T; Siepmann J; Goepferich A
    Int J Pharm; 2006 May; 314(2):161-9. PubMed ID: 16551497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How porosity and size affect the drug release mechanisms from PLGA-based microparticles.
    Klose D; Siepmann F; Elkharraz K; Krenzlin S; Siepmann J
    Int J Pharm; 2006 May; 314(2):198-206. PubMed ID: 16504431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
    Elkharraz K; Faisant N; Guse C; Siepmann F; Arica-Yegin B; Oger JM; Gust R; Goepferich A; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):127-36. PubMed ID: 16490330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
    Güres S; Siepmann F; Siepmann J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confocal microscopy for the elucidation of mass transport mechanisms involved in protein release from lipid-based matrices.
    Koennings S; Tessmar J; Blunk T; Göpferich A
    Pharm Res; 2007 Jul; 24(7):1325-35. PubMed ID: 17457662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release implants based on cast lipid blends.
    Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Sci; 2011 May; 43(1-2):78-83. PubMed ID: 21463679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous controlled vitamin release from multiparticulates: theory and experiment.
    Seidenberger T; Siepmann J; Bley H; Maeder K; Siepmann F
    Int J Pharm; 2011 Jun; 412(1-2):68-76. PubMed ID: 21515349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug release mechanisms of cast lipid implants.
    Kreye F; Siepmann F; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):394-400. PubMed ID: 21352913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants.
    Herrmann S; Mohl S; Siepmann F; Siepmann J; Winter G
    Pharm Res; 2007 Aug; 24(8):1527-37. PubMed ID: 17380261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA implants: How Poloxamer/PEO addition slows down or accelerates polymer degradation and drug release.
    Hamoudi-Ben Yelles MC; Tran Tan V; Danede F; Willart JF; Siepmann J
    J Control Release; 2017 May; 253():19-29. PubMed ID: 28284831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.